Rhino Health
22 Boston Wharf Rd 7th Floor, Boston, Massachusetts, 02210, United States
Overview
Rhino Federated Computing provides a platform for federated AI collaboration that enables enterprises to run AI and data science initiatives without centralizing data. The platform emphasizes protecting data ownership, complying with regulation, and accelerating multi‑party innovation. Founded in 2020 by Dr. Ittai Dayan and Yuval Baror, the company is based in Boston and maintains an R&D center in Tel Aviv. Rhino is already powering use cases including federated GenAI for biopharmaceutical R&D, healthcare data harmonization and federated collaboration, and financial‑crime and fraud detection for financial institutions. The company raised $15M in a Series A and has now raised over $30M to date. Rhino plans to use the new capital to scale capabilities across more customers and regulated sectors and to bring an enterprise‑grade federated AI solution to market. Rhino Health builds healthcare AI infrastructure that connects medical data sources with researchers while preserving patient privacy and IP confidentiality. The company develops solutions using federated learning and edge computing to enable secure, decentralized data processing and AI model training. Rhino Health has enabled partners to create networks of health systems, life sciences companies, and public sector organizations for cross-continent data collaborations. Led by CEO Dr. Ittai Dayan, the company emphasizes privacy-preserving approaches to accelerate healthcare research. The company received an investment intended to fund continued design of its federated and edge computing solutions; the amount was not disclosed. Rhino Health operates a platform that connects hospitals and AI developers, providing access to a large, continually updated, distributed dataset from a diverse group of patients. The core product enables clinical AI model development across different institutions and patient demographics. Rhino is collaborating with NVIDIA to bring federated learning into clinical settings and is using NVIDIA Clara to support cross-geography and cross-device model training. The company is a member of the NVIDIA Inception program and maintains an R&D center in Tel Aviv, Israel. Rhino closed a $5M seed financing round led by LionBird Ventures, with participation from Arkin Holdings and several angel investors. The company is led by CEO Ittai Dayan, MD, and CTO Yuval Baror.
- Total raised
- $20M
- Funding rounds
- 3
- Latest round
- Series A
- Latest activity
- May 2025
Industries
- Artificial Intelligence (AI)
- Health Care
- Information Technology
- Software
Recent funding
Series A
May 2025
$15M
Seed
Feb 2021
$5M